Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Manmeet S Ahluwalia, Mital Patel & David M Peereboom. (2011) Role of tyrosine kinase inhibitors in the management of high-grade gliomas. Expert Review of Anticancer Therapy 11:11, pages 1739-1748.
Read now
Read now
Hung Huynh. (2010) Tyrosine kinase inhibitors to treat liver cancer. Expert Opinion on Emerging Drugs 15:1, pages 13-26.
Read now
Read now
Articles from other publishers (19)
Hammad Zafar, Mamoon Ur Rashid, Deepika Sarvepalli, Muzammil Muhammad Khan, Bayarmaa Mandzhieva, Akriti Gupta Jain, Rima Shobar, Anum Jalil & Sarfraz Ahmad. 2020. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers
287
302
.
Akinobu Taketomi. (2016) Clinical trials of antiangiogenic therapy for hepatocellular carcinoma. International Journal of Clinical Oncology 21:2, pages 213-218.
Crossref
Crossref
Claus Hellerbrand & Ramin Massoumi. (2016) Cylindromatosis-A Protective Molecule against Liver Diseases. Medicinal Research Reviews 36:2, pages 342-359.
Crossref
Crossref
Wonseok Kang, Joon Seok Lim, Mi-Suk Park, Gou Young Koh & Honsoul Kim. (2016) Antiangiogenic Therapy Induces Hepatic Tumor Vascular Network Rearrangement to Receive Perfusion via the Portal Vein and Hepatic Artery. Journal of Vascular Research 53:1-2, pages 72-82.
Crossref
Crossref
Anne-Christine Piguet, Michaela Medová, Adrian Keogh, Astrid A. Glück, Daniel M. Aebersold, Jean-François Dufour & Yitzhak Zimmer. (2015) Impact of MET targeting on tumor-associated angiogenesis and growth of MET mutations-driven models of liver cancer. Genes & Cancer 6:7-8, pages 317-327.
Crossref
Crossref
Jing Chen, Chengya Zhou, Yu Long & Xude Yin. (2014) Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study. Tumor Biology 36:1, pages 183-191.
Crossref
Crossref
Carlo Barone, Michele Basso, Marco Biolato, Maurizio Pompili, Vittoria Rufini, Luca Miele, Maria Basso, Anna Maria De Gaetano, Paola Castaldi, Alessandro Iaculli, Lucia Leccisotti, Laura Riccardi & Antonio Grieco. (2013) A phase II study of sunitinib in advanced hepatocellular carcinoma. Digestive and Liver Disease 45:8, pages 692-698.
Crossref
Crossref
Chandrajit P. Raut, Yves Boucher, Dan G. Duda, Jeffrey A. Morgan, Richard Quek, Marek Ancukiewicz, Johanna Lahdenranta, J. Paul Eder, George D. Demetri & Rakesh K. Jain. (2012) Effects of Sorafenib on Intra-Tumoral Interstitial Fluid Pressure and Circulating Biomarkers in Patients with Refractory Sarcomas (NCI Protocol 6948). PLoS ONE 7:2, pages e26331.
Crossref
Crossref
Renumathy Dhanasekaran & Roniel Cabrera. 2012. Primary Liver Cancer. Primary Liver Cancer
263
290
.
Cui-cui Sun, Yu-sheng Zhang, Xia Xue, Yan-na Cheng, Hui-ping Liu, Cui-rong Zhao, Hong-xiang Lou & Xian-jun Qu. (2011) Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma. European Journal of Pharmacology 667:1-3, pages 136-143.
Crossref
Crossref
Rajeev S. Samant & Lalita A. Shevde. (2011) Recent Advances in Anti-Angiogenic Therapy of Cancer. Oncotarget 2:3, pages 122-134.
Crossref
Crossref
Beverly A. Teicher, Rebecca G. Bagley, Cecile Rouleau, Ariel Kruger, Yi Ren & Leslie Kurtzberg. (2011) Characteristics of human Ewing/PNET sarcoma models. Annals of Saudi Medicine 31:2, pages 174-182.
Crossref
Crossref
Beverly A. Teicher. (2011) Antiangiogenic agents and targets: A perspective. Biochemical Pharmacology 81:1, pages 6-12.
Crossref
Crossref
Melanie B. ThomasDeborah JaffeMichael M. ChotiJacques BelghitiSteven CurleyYuman FongGregory GoresRobert KerlanPhillipe MerleBert O'NeilRonnie PoonLawrence SchwartzJoel TepperFrancis YaoDaniel HallerMargaret MooneyAlan Venook. (2010) Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting. Journal of Clinical Oncology 28:25, pages 3994-4005.
Crossref
Crossref
Hung Huynh. (2010) Molecularly targeted therapy in hepatocellular carcinoma. Biochemical Pharmacology 80:5, pages 550-560.
Crossref
Crossref
Camillo Porta & Chiara Paglino. (2010) Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib. World Journal of Hepatology 2:3, pages 103.
Crossref
Crossref
Sandrine J. Faivre, Mohamed Bouattour, Chantal Dreyer & Eric Raymond. (2009) Sunitinib in Hepatocellular Carcinoma: Redefining Appropriate Dosing, Schedule, and Activity End Points. Journal of Clinical Oncology 27:35, pages e248-e250.
Crossref
Crossref
Su-Bo Wang, Yan-Na Cheng, Shu-Xiang Cui, Julia Li Zhong, S. G. Ward, Li-Rui Sun, Ming-Hui Chen, Norihiro Kokudo, Wei Tang & Xian-Jun Qu. (2009) Des-γ-carboxy prothrombin stimulates human vascular endothelial cell growth and migration. Clinical & Experimental Metastasis 26:5, pages 469-477.
Crossref
Crossref
Yao-Kang Huang, Kui-Lin Cheng & Chung-Shi Wang. (2009) A Case of Liver Metastasis From Colon Cancer Mimicking Infiltrating Hepatoma With Portal Vein Thrombosis. Journal of Medical Ultrasound 17:4, pages 212-217.
Crossref
Crossref